In Focus: decentralized manufacturing
Decentralized manufacturing, also referred to as ‘redistributed manufacturing’, divides the manufacturing capacity for cell and gene therapies between multiple sites. This strategy can enable manufacturing to occur closer to the final point of administration, can be customized to the end user and can minimize the length of the distribution chain.
In this In Focus feature, which has been produced in association with Thermo Fisher Scientific (CA, USA), we explore how closed modular cell therapy workflows have the potential to overcome manufacturing hurdles. We also delve further into how this closed-system approach could result in a reduction in touchpoints and guide you through a typical vein-to-vein process.
In association with: